注射用脂溶性维生素(Ⅱ)/水溶性维生素与常用电解质配伍的稳定性考察
x
请在关注微信后,向客服人员索取文件
篇名: | 注射用脂溶性维生素(Ⅱ)/水溶性维生素与常用电解质配伍的稳定性考察 |
TITLE: | |
摘要: | 目的:考察注射用脂溶性维生素(Ⅱ)/水溶性维生素与常用电解质的配伍稳定性。方法:参考临床常用剂量,取注射用脂溶性维生素(Ⅱ)/水溶性维生素组合包装[含注射用脂溶性维生素(Ⅱ)2瓶和注射用水溶性维生素1瓶]分别与葡萄糖注射液、氯化钾注射液、浓氯化钠注射液、碳酸氢钠注射液、门冬氨酸钾注射液、门冬氨酸钾镁注射液、甘油磷酸钠注射液、多种微量元素注射液(Ⅱ)配伍,得配伍液A~H。在室温(25 ℃)下,分别于0、1、2、3、4 h时考察各配伍液的外观、pH值、渗透压摩尔浓度和不溶性微粒数,并于0、4 h时检查其细菌内毒素含量。结果:配制后4 h内,各配伍液外观无明显变化;配伍液H的pH值变化较大(RSD=5.13%,n=5),配伍液D和配伍液G的pH值明显升高;各配伍液的渗透压摩尔浓度均无明显变化(RSD<2%,n=5),且小于600 mOsmol/kg;各配伍液细菌内毒素检查结果均为阴性。配制后2、4 h时,配伍液B中≥10 μm的微粒数明显增加;配制后2、3、4 h时,配伍液E、F、H中≥10 μm的微粒数明显增加;配制后0、1、2、3、4 h时,配伍液G中≥10 μm的微粒数明显增加;上述配伍液中≥10 μm的微粒数与同时间点的配伍液A比较,差异均有统计学意义(P<0.05),但均符合2015年版药典标准。配制后1、2、3、4 h时,配伍液D中≥10 μm的微粒数明显增加,与同时间点的配伍液A比较,差异均有统计学意义(P<0.05);且配制后2、3、4 h时≥10 μm的微粒数均超出药典规定范围。配制后4 h内,配伍液C中≥10 μm的微粒数和各配伍液中≥25 μm的微粒数均无明显变化,且符合药典标准。结论:由于pH值和不溶性微粒数变化较大,注射用脂溶性维生素(Ⅱ)/水溶性维生素不宜与多种微量元素注射液(Ⅱ)、甘油磷酸钠注射液或碳酸氢钠注射液配伍使用。 |
ABSTRACT: | OBJECTIVE: To investigate the compatibility stability of Fat-soluble vitamin (Ⅱ) /Water-soluble vitamin for injection with common electrolytes. METHODS: Referring to clinical common dose, Fat-soluble vitamin (Ⅱ) for injection /Water-soluble vitamin for injection collective packing [containing Fat-soluble vitamin(Ⅱ) for injection 2 ampoules and Water-soluble for injection 1 ampoule] were respectively mixed with Glucose injection, Potassium chloride injection, Concentrated sodium chloride injection, Sodium bicarbonate injection, Potassium aspartate injection, Potassium aspartate and magnesium aspartate injection, Sodium glycerophosphate injection, Multi-trace elements injection (Ⅱ) to obtain mixture A-H. At room temperature (25 ℃), these mixtures were investigated in terms of appearance, pH value, osmotic pressure molar concentration and the number of insoluble particles at 0, 1, 2, 3, 4 h. The contents of bacterial endotoxin were tested at 0, 4 h. RESULTS: Within 4 h after mixing, there was no significant change in appearance of those mixtures; pH value of mixture H changed greatly (RSD=5.13%, n=5), and that of mixture D and G increased significantly. The osmotic pressure molar concentration of those mixtures had no significantly change (RSD<2%,n=5) and lower than 600 mOsmol/kg. The bacterial endotoxin tests of those mixtures were negative. Two and four hours after mixing, the number of insoluble particles ≥10 μm in mixture B was increased significantly; 2, 3, 4 h after mixing, the number of insoluble particles ≥10 μm in mixture E, F, H were increased significantly; 0 ,1, 2, 3, 4 h after mixing, the number of insoluble particles ≥10 μm in mixture G was increased significantly. There was statistical significance in the number of insoluble particle ≥10 μm in above mixtures compared to mixture A at the same time point (P<0.05), but it was in line with the standard of 2015 pharmacopeia. One, two, three and four hours after mixing, the number of insoluble particle ≥10 μm in mixture D was increased significantly, there was statistical significance compared to mixture A at the same time point (P<0.05); the number of insoluble particle ≥10 μm in mixture D was beyond prescribed scope of pharmacopeia at 2, 3, 4 h after mixing. Within 4 h after mixing, both the number of insoluble particle ≥10 μm in mixture C and the number of insoluble particle ≥25 μm in edch mixture had no significant change, in accordance with pharmacopeia standard. CONCLUSIONS: Fat-soluble vitamin (Ⅱ)/Water-soluble vitamin for injection is not suitable for mixing with Multi-trace elements injection (Ⅱ), Sodium glycerophosphate injection or Sodium bicarbonate injection due to great change of pH value and the number of insoluble particles. |
期刊: | 2017年第28卷第11期 |
作者: | 范静,李相成,李飞,潘东,刘丽洁,李静,孙伟 |
AUTHORS: | FAN Jing, LI Xiangcheng, LI Fei, PAN Dong, LIU Lijie, LI Jing, SUN Wei |
关键字: | 注射用脂溶性维生素(Ⅱ);注射用水溶性维生素;电解质;配伍;稳定性 |
KEYWORDS: | Fat-soluble vitamin for injection (Ⅱ); Water-soluble vitamin for injection; Electrolyte; Compatibility; Stability |
阅读数: | 2729 次 |
本月下载数: | 39 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!